Phase
Condition
Myasthenia Gravis (Chronic Weakness)
Neurologic Disorders
Memory Loss
Treatment
N/AClinical Study ID
Ages 35-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Early ALS Inclusion Criteria:
Sporadic or familial ALS (as defined by revised El Escorial criteria)
Onset of weakness or spasticity due to ALS ≤ 36 months prior to the Screening/BaselineVisit.
Slow vital capacity (SVC) ≥60% of predicted for gender, height, and age
Exclusion
Early ALS Exclusion Criteria:
The presence of unstable psychiatric disease, cognitive impairment, or dementia thatwould impair ability of the subject to provide informed consent, or a history of activesubstance abuse within the prior year. ALS Disease Mimics Inclusion Criteria:
Diagnosis of one of the following: a. Pure Lower Motor Neuron Disease (LMND) mimics: i. Multi-focal motor neuropathy ii.Autoimmune motor neuropathy iii. Cervical or lumbosacral radiculopathies with weaknessinvolving more than one extremity or more than a single myotome if restricted to oneextremity. iv. Multiple peripheral mononeuropathies with clinical weakness v. Charcot-Marie-ToothDisease vi. Any condition that produces generalized or localized weakness withoutconcomitant sensory symptoms, including myasthenia gravis or myopathy, that the evaluatingphysician deems mimics ALS. b. Pure Upper Motor Neuron Disease (UMND) mimics: i. Cervical myelopathy ii. Multiplesclerosis iii. Hereditary spastic paraparesis ALS Disease Mimics Exclusion Criteria:
Diagnosis of possible, probable, probable-laboratory supported, or definite ALS
Presence of positive family history of ALS.
The presence of unstable psychiatric disease, cognitive impairment, or dementia thatwould impair ability of the subject to provide informed consent, or a history ofactive substance abuse within the prior year. Healthy Volunteer Inclusion Criteria:
Absence of a known neurological disorder. Healthy Volunteer Exclusion Criteria:
History of ALS, myopathy, neuropathy, ALS mimic disorder or other neurodegenerativedisease.
Presence of positive family history of ALS.
The presence of unstable psychiatric disease, cognitive impairment, or dementia thatwould impair ability of the subject to provide informed consent, or a history ofactive substance abuse within the prior year.
Please note that this is not a complete listing on all eligibility criteria.
Study Design
Study Description
Connect with a study center
St. Joseph's Hospital & Medical Center
Phoenix, Arizona 85013
United StatesSite Not Available
University of Miami Miller School of Medicine
Miami, Florida 33136
United StatesSite Not Available
Massachusetts General Hospital
Boston, Massachusetts 02114
United StatesSite Not Available
Skulpt, Inc
Boston, Massachusetts 02210
United StatesSite Not Available
SUNY Upstate Medical University
Syracuse, New York 13210
United StatesSite Not Available
Wake Forest University Health Sciences
Winston-Salem, North Carolina 27157
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.